Skip to main content

Intellispace Cardiovascular

4 CVEs product

Monthly

CVE-2018-14789 MEDIUM This Month

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may. Rated medium severity (CVSS 6.7), this vulnerability is low attack complexity. No vendor patch available.

RCE Intellispace Cardiovascular Xcelera
NVD
CVSS 3.1
6.7
EPSS
0.4%
CVE-2018-14787 HIGH This Week

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. No vendor patch available.

Privilege Escalation RCE Intellispace Cardiovascular Xcelera
NVD
CVSS 3.1
7.8
EPSS
0.4%
CVE-2018-5438 MEDIUM This Month

Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. Rated medium severity (CVSS 6.3). No vendor patch available.

Authentication Bypass Microsoft Intellispace Cardiovascular
NVD
CVSS 3.0
6.3
EPSS
0.5%
CVE-2017-14111 HIGH This Week

The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an. Rated high severity (CVSS 7.2), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure Intellispace Cardiovascular Xcelera
NVD
CVSS 3.0
7.2
EPSS
1.0%
EPSS 0% CVSS 6.7
MEDIUM This Month

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may. Rated medium severity (CVSS 6.7), this vulnerability is low attack complexity. No vendor patch available.

RCE Intellispace Cardiovascular Xcelera
NVD
EPSS 0% CVSS 7.8
HIGH This Week

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain. Rated high severity (CVSS 7.8), this vulnerability is low attack complexity. No vendor patch available.

Privilege Escalation RCE Intellispace Cardiovascular +1
NVD
EPSS 0% CVSS 6.3
MEDIUM This Month

Philips ISCV application prior to version 2.3.0 has an insufficient session expiration vulnerability where an attacker could reuse the session of a previously logged in user. Rated medium severity (CVSS 6.3). No vendor patch available.

Authentication Bypass Microsoft Intellispace Cardiovascular
NVD
EPSS 1% CVSS 7.2
HIGH This Week

The workstation logging function in Philips IntelliSpace Cardiovascular (ISCV) 2.3.0 and earlier and Xcelera R4.1L1 and earlier records domain authentication credentials, which if accessed allows an. Rated high severity (CVSS 7.2), this vulnerability is remotely exploitable, low attack complexity. No vendor patch available.

Information Disclosure Intellispace Cardiovascular Xcelera
NVD

This site uses cookies essential for authentication and security. No tracking or analytics cookies are used. Privacy Policy